Zacks Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-136,133
Closed -$7.54M 702
2016
Q2
$7.54M Sell
136,133
-1,644
-1% -$90.6K 0.23% 108
2016
Q1
$7.36M Buy
137,777
+3,690
+3% +$182K 0.23% 111
2015
Q4
$6.9M Buy
134,087
+4,324
+3% +$215K 0.23% 119
2015
Q3
$5.86M Sell
129,763
-1,438
-1% -$67.9K 0.2% 121
2015
Q2
$6.07M Buy
131,201
+99,569
+315% +$4.36M 0.19% 125
2015
Q1
$1.36M Buy
+31,632
New +$1.21M 0.04% 227
2014
Q3
Sell
-8,276
Closed -$280K 733
2014
Q2
$280K Buy
+8,276
New +$265K 0.01% 592
2014
Q1
Sell
-14,363
Closed -$514K 752
2013
Q4
$514K Buy
14,363
+1,901
+15% +$63.1K 0.02% 378
2013
Q3
$375K Buy
+12,462
New +$407K 0.02% 443

Other funds holding PBH

Zacks Investment Management's PBH Position: Q3 2016 in Review

Zacks Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 136,133 shares — an estimated $7.54M sold.

Zacks Investment Management first reported a position in PBH in Q3 2013 and held it in 9 quarters. The position peaked at $7.54M in Q2 2016. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Zacks Investment Management reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Zacks Investment Management sold 136,133 Prestige Consumer Healthcare shares in Q3 2016, an estimated $7.54M.
  • Zacks Investment Management first reported a position in Prestige Consumer Healthcare in Q3 2013 and held it in 9 quarters.
  • Zacks Investment Management's Prestige Consumer Healthcare position peaked at $7.54M in Q2 2016.
  • 243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Zacks Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.